Journal article 590 views
Mammographic dysplasia as entry criterion for breast cancer prevention trials
The Lancet, Volume: 337, Issue: 8751, Start page: 1225
Swansea University Author: Damon Berridge
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/0140-6736(91)92897-b
Abstract
Mammographic dysplasia as entry criterion for breast cancer prevention trials
Published in: | The Lancet |
---|---|
ISSN: | 01406736 |
Published: |
Elsevier BV
1991
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa27678 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2016-05-04T01:33:19Z |
---|---|
last_indexed |
2018-02-09T05:11:02Z |
id |
cronfa27678 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2016-05-03T15:55:58.7141449</datestamp><bib-version>v2</bib-version><id>27678</id><entry>2016-05-03</entry><title>Mammographic dysplasia as entry criterion for breast cancer prevention trials</title><swanseaauthors><author><sid>a3def496492ff026f3228f50fbf89525</sid><ORCID>0000-0002-5442-6686</ORCID><firstname>Damon</firstname><surname>Berridge</surname><name>Damon Berridge</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-05-03</date><deptcode>HDAT</deptcode><abstract/><type>Journal Article</type><journal>The Lancet</journal><volume>337</volume><journalNumber>8751</journalNumber><paginationStart>1225</paginationStart><publisher>Elsevier BV</publisher><issnPrint>01406736</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>5</publishedMonth><publishedYear>1991</publishedYear><publishedDate>1991-05-31</publishedDate><doi>10.1016/0140-6736(91)92897-b</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-05-03T15:55:58.7141449</lastEdited><Created>2016-05-03T14:20:06.8466649</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Jack</firstname><surname>Cuzick</surname><order>1</order></author><author><firstname>Damon</firstname><surname>Berridge</surname><orcid>0000-0002-5442-6686</orcid><order>2</order></author><author><firstname>John</firstname><surname>Whitehead</surname><order>3</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2016-05-03T15:55:58.7141449 v2 27678 2016-05-03 Mammographic dysplasia as entry criterion for breast cancer prevention trials a3def496492ff026f3228f50fbf89525 0000-0002-5442-6686 Damon Berridge Damon Berridge true false 2016-05-03 HDAT Journal Article The Lancet 337 8751 1225 Elsevier BV 01406736 31 5 1991 1991-05-31 10.1016/0140-6736(91)92897-b COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University 2016-05-03T15:55:58.7141449 2016-05-03T14:20:06.8466649 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Jack Cuzick 1 Damon Berridge 0000-0002-5442-6686 2 John Whitehead 3 |
title |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
spellingShingle |
Mammographic dysplasia as entry criterion for breast cancer prevention trials Damon Berridge |
title_short |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
title_full |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
title_fullStr |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
title_full_unstemmed |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
title_sort |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
author_id_str_mv |
a3def496492ff026f3228f50fbf89525 |
author_id_fullname_str_mv |
a3def496492ff026f3228f50fbf89525_***_Damon Berridge |
author |
Damon Berridge |
author2 |
Jack Cuzick Damon Berridge John Whitehead |
format |
Journal article |
container_title |
The Lancet |
container_volume |
337 |
container_issue |
8751 |
container_start_page |
1225 |
publishDate |
1991 |
institution |
Swansea University |
issn |
01406736 |
doi_str_mv |
10.1016/0140-6736(91)92897-b |
publisher |
Elsevier BV |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
published_date |
1991-05-31T03:33:37Z |
_version_ |
1763751407642476544 |
score |
11.036116 |